Cathay Biotech (China) Investor Sentiment

688065 Stock   42.84  0.22  0.51%   
About 56% of Cathay Biotech's investor base is looking to short. The analysis of overall sentiment of trading Cathay Biotech stock suggests that many investors are alarmed at this time. The current market sentiment, together with Cathay Biotech's historical and current headlines, can help investors time the market. In addition, many technical investors use Cathay Biotech stock news signals to limit their universe of possible portfolio assets.
  
over three months ago at news.google.com         
Cathay International Holdings Limited Stock Price Passes Above Fifty Day Moving Average of 0.75 - De...
Google News at Macroaxis
over three months ago at news.google.com         
Skytrax Releases Worlds Best Airline Ranking CATHAY PAC AIR Rises from 3 Notches to 5th Place - AAST...
Google News at Macroaxis
over three months ago at news.google.com         
Cathay General Bancorp Receives Consensus Rating of Hold from Analysts - Defense World
Google News at Macroaxis
over six months ago at news.google.com         
There Are Reasons To Feel Uneasy About Cathay Biotechs Returns On Capital - Simply Wall St
Google News at Macroaxis
over six months ago at news.google.com         
FAA Investigates Pilot Training Incidents for CATHAY PAC AIR - AASTOCKS.com
Google News at Macroaxis
over six months ago at news.google.com         
SPDR SP Biotech ETF Stock Position Raised by Tower Research Capital LLC TRC - Defense World
Google News at Macroaxis
over six months ago at news.google.com         
Cathay General Bancorp Sees Significant Decline in Short Interest - MarketBeat
Google News at Macroaxis
over six months ago at news.google.com         
Cathay Biotech Has A Somewhat Strained Balance Sheet - Simply Wall St
Google News at Macroaxis
over six months ago at news.google.com         
Charles Schwab Investment Management Inc. Purchases 25,421 Shares of Cathay General Bancorp - Market...
Google News at Macroaxis
over six months ago at news.google.com         
What Cathay Biotech Inc.s 27 percent Share Price Gain Is Not Telling You - Simply Wall St
Google News at Macroaxis
over six months ago at news.google.com         
We Think That There Are More Issues For Cathay Biotech Than Just Sluggish Earnings - Simply Wall St
Google News at Macroaxis
over six months ago at news.google.com         
FY2024 EPS Estimates for Cathay General Bancorp Boosted by DA Davidson - MarketBeat
Google News at Macroaxis
over six months ago at news.google.com         
Cathay Biotech Inc.s stock price dropped 13 percent last week private companies would not be happy -...
Google News at Macroaxis
over six months ago at news.google.com         
Global market update APAC shares open mixed, tech stocks drive US rebound - Investing.com Australia
Google News at Macroaxis
over six months ago at news.google.com         
Does The Market Have A Low Tolerance For Cathay Biotech Inc.s Mixed Fundamentals - Simply Wall St
Google News at Macroaxis
Far too much social signal, news, headlines, and media speculation about Cathay Biotech that are available to investors today. That information is available publicly through Cathay media outlets and privately through word of mouth or via Cathay internal channels. However, regardless of the origin, that massive amount of Cathay data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Cathay Biotech news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Cathay Biotech relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Cathay Biotech's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Cathay Biotech alpha.

Cathay Biotech Performance against Dow Jones

 Price Growth (%)  
       Timeline  
1
What Cathay Biotech Inc.s 38 percent Share Price Gain Is Not Telling You - Simply Wall St
10/22/2024
2
Cathay General Bancorp Shares Purchased by Dean Investment Associates LLC - MarketBeat
12/09/2024

Complementary Tools for Cathay Stock analysis

When running Cathay Biotech's price analysis, check to measure Cathay Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cathay Biotech is operating at the current time. Most of Cathay Biotech's value examination focuses on studying past and present price action to predict the probability of Cathay Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cathay Biotech's price. Additionally, you may evaluate how the addition of Cathay Biotech to your portfolios can decrease your overall portfolio volatility.
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm